Real-world outcomes of finerenone in primary aldosteronism
Study context
- Population
- Primary aldosteronism (PA) patients on eplerenone forced to switch to finerenone during a national shortage
- Comparison
- Finerenone vs prior eplerenone
- Outcome
- BP control and biochemical response during finerenone treatment
Methodological detailsforced switch from eplerenone to finerenone during a national shortage
- Forced switch from eplerenone to finerenone during a national shortage
Main finding
As reported in the abstract
- Proportion of patients with normal BP decreased
- P = .004
- Proportion with complete biochemical response decreased
- P = .008
Original publication
Real-world outcomes of finerenone in primary aldosteronism. Eur J Endocrinol. Published 16 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →